The act of building trust with your pharmaceutical and biotech clients is similar to how trust is built between friends – both require time, mutual respect and appreciation. However, the components required to build trust between a CRO and its clients are complicated due to the involvement of various teams in this matrix relationship. I will discuss how numerous teams within the CRO and sponsor organization work together to establish trust, and ultimately a fruitful partnership.

[EPISODE 20] Dr. David Johnson Talks Frosted Flakes, Small Molecules, and Pharmacokinetics!
On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix